Frontlight ResearchEarly access
Trial site
Northern Light Acadia Hospital
- 1running trial
- 4closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 21 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Cognito Therapeutics, Inc.2 trials
- Annovis Bio Inc.1 trial
- Biohaven Pharmaceuticals, Inc.1 trial
- Vivoryon Therapeutics N.V.1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Completed
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Terminated
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Site data: ClinicalTrials.govUpdated 15 Nov 2026